Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $17.76 Analyst target: $38.44 Upside: 116.44%
Prenetics Global Ltd (PRE) is an innovative health technology company that specializes in advanced genetic and diagnostic testing solutions, offering invaluable health insights to consumers and healthcare professionals alike. With a robust focus on research and development, Prenetics has built a strong international footprint through strategic partnerships and collaborations, enhancing its market visibility. As a frontrunner in personalized medicine, the company is strategically positioned to leverage the growing demand for accessible health data, presenting a compelling investment opportunity within the dynamic healthcare sector.
See the full interactive analysis & chart →Informational only — not investment advice.